216765-95-6 Usage
Uses
Used in Pharmaceutical Industry:
(3-Bromo-5-trifluoromethyl-pyridin-2-yl)-dimethyl-amine is used as a building block for the synthesis of various bioactive molecules. Its unique structure and functional groups contribute to the development of new drugs, making it a crucial component in drug discovery and development processes.
Used in Agrochemical Industry:
In the agrochemical industry, (3-Bromo-5-trifluoromethyl-pyridin-2-yl)-dimethyl-amine is utilized as a building block for the synthesis of pesticides. Its chemical properties allow for the creation of effective compounds that can be used to protect crops and enhance agricultural productivity.
Used in Research Laboratories:
(3-Bromo-5-trifluoromethyl-pyridin-2-yl)-dimethyl-amine is also used as a reagent for chemical synthesis in research laboratories. Its distinctive properties make it an essential tool for scientists working on the development of new chemical compounds and materials.
Used as a Reference Standard for Analytical Testing:
Due to its well-defined chemical structure, (3-Bromo-5-trifluoromethyl-pyridin-2-yl)-dimethyl-amine serves as a reference standard for analytical testing. It helps ensure the accuracy and reliability of experimental results in various research and quality control applications.
Check Digit Verification of cas no
The CAS Registry Mumber 216765-95-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,6,7,6 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 216765-95:
(8*2)+(7*1)+(6*6)+(5*7)+(4*6)+(3*5)+(2*9)+(1*5)=156
156 % 10 = 6
So 216765-95-6 is a valid CAS Registry Number.
216765-95-6Relevant academic research and scientific papers
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
-
Paragraph 2050, (2019/03/30)
The invention discloses compounds of Formula (I), wherein A1, R1, R2, R3, R4, and n are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
